Cite
HARVARD Citation
Kraus, S. et al. (n.d.). Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States. Neurourology and urodynamics. 39 (8), pp. 2206-2222. [Online].